BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7013722)

  • 1. Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels.
    Luyckx AS; Mendoza E; Lefebvre P
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):305-13. PubMed ID: 7013722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism during exercise in man: the role of insulin in the regulation of glucose utilization.
    Lavoie C; Ducros F; Bourque J; Langelier H; Chiasson JL
    Can J Physiol Pharmacol; 1997 Jan; 75(1):36-43. PubMed ID: 9101063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.
    Paquot N; Scheen AJ; Franchimont P; Lefebvre PJ
    Diabete Metab; 1988; 14(1):31-6. PubMed ID: 3292305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
    Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
    Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
    Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon during pentobarbitone anaesthesia.
    Bailey CJ; Flatt PR
    Diabete Metab; 1980 Jun; 6(2):91-5. PubMed ID: 6997105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.
    Kuku SF; Jaspan JB; Emmanouel DS; Katz AI; Rubenstein AH
    Horm Metab Res; 1978 Mar; 10(2):99-100. PubMed ID: 649048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting increases the plasma glucagon response in the migratory garden warbler (Sylvia borin).
    Totzke U; Hübinger A; Korthaus G; Bairlein F
    Gen Comp Endocrinol; 1999 Jul; 115(1):116-21. PubMed ID: 10375470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects.
    Sechi LA; Marigliano A; Tedde R
    Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of insulin and epinephrine in human metabolism: their influence on carbohydrate and lipid oxidation rate.
    Müller-Hess R; Geser CA; Pittet P; Chappuis P; Jéquier E; Felber JP
    Diabete Metab; 1975 Sep; 1(3):151-7. PubMed ID: 1234578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects.
    Scheen A; Cession-Fossion A; Scheen-Lavigne M; Luyckx A
    Horm Metab Res; 1982 May; 14(5):240-5. PubMed ID: 7047346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of furosemide on insulin and glucagon responses to arginine in normal subjects.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    Diabetologia; 1980 Apr; 18(4):293-6. PubMed ID: 6998800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
    Krzentowski G; Scheen A; Castillo M; Luyckx AS; Lefèbvre PJ
    Diabetologia; 1983 May; 24(5):314-8. PubMed ID: 6347779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.